Evidence map›Paper›PMID 34396408›Full record

ArticleThe Journal of infectious diseases2021

Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.

Kristie L Connolly, Michelle Pilligua-Lucas, Carolina Gomez, Allison C Costenoble-Caherty, Anthony Soc, Knashka Underwood, Andrew N Macintyre, Gregory D Sempowski, Ann E Jerse

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Clinical microbiology reviews · 2024
    Review
  8. Article
  9. Article
  10. Microbiology spectrum · 2023
    Article
  11. Review
  12. PotentmSphere · 2022
    Article
  13. Tissue Models forFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kristie L ConnollyDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Michelle Pilligua-LucasDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Carolina GomezDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Allison C Costenoble-CahertyDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Anthony SocDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Knashka UnderwoodDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Andrew N MacintyreDuke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Gregory D SempowskiDuke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Ann E JerseDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
Uniformed Services University of the Health Sciences · USDuke University · US

Funding

Regional Biocontainment Laboratory (RBL)UC6AI058607 · NIAID · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 2003 to 2005
$16.3M
The Gonorrhea Vaccine Cooperative Research CenterU19AI144180 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI CHACKERIAN, BRYCE C · 2019 to 2023
$10.7M
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (ACU19AI113170 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI JERSE, ANN E. · 2014 to 2018
$6.9M
NIAID NIH HHS U19 AI113170NIAID NIH HHS U19 AI144180NIAID NIH HHS UC6 AI058607
6 · The paper itself

Abstract

Murine models of Neisseria gonorrhoeae lower reproductive tract infection are valuable systems for studying N. gonorrhoeae adaptation to the female host and immune responses to infection. These models have also accelerated preclinical testing of candidate therapeutic and prophylactic products against gonorrhea. However, because N. gonorrhoeae infection is restricted to the murine cervicovaginal region, there is a need for an in vivo system for translational work on N. gonorrhoeae pelvic inflammatory disease (PID). Here we discuss the need for well-characterized preclinical upper reproductive tract infection models for developing candidate products against N. gonorrhoeae PID, and report a refinement of the gonorrhea mouse model that supports sustained upper reproductive tract infection. To establish this new model for vaccine testing, we also tested the licensed meningococcal 4CMenB vaccine, which cross-protects against murine N. gonorrhoeae lower reproductive tract infection, for efficacy against N. gonorrhoeae in the endometrium and oviducts following transcervical or vaginal challenge.

Indexed as

AnimalsAnti-Infective AgentsDisease Models, AnimalFemaleGonorrheaMiceNeisseria gonorrhoeaePelvic Inflammatory DiseaseReproductive Tract InfectionsAnti-Infective AgentsantibioticsgonorrheamousePIDreproductive tractvaccinevaginal microbicides

Identifiers

PMID34396408
PMCPMC8365121
OpenAlexW3196101940

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.